There are no approved treatments or preventive drugs against the deadly virus.
As the death toll in the West Africa Ebola
outbreak passes 1,000, the U.S. Food and Drug Administration is warning
against products sold online that claim to treat the deadly disease or
prevent infection.
Since the start of the Ebola outbreak in West
Africa, the FDA has received a number of consumer complaints about bogus
products, the agency said in a statement released Thursday.
However,
"there are no approved vaccines, drugs, or investigational products
specifically for Ebola available for purchase on the Internet," the FDA
said.
"Individuals promoting these unapproved and fraudulent
products must take immediate action to correct or remove these claims or
face potential FDA action," the agency added.
It is also against the law for makers of dietary supplements to claim that their products prevent or cure disease, the FDA said.
Some
experimental Ebola vaccines and treatments are being developed, but
they are still in the early stages and have not undergone thorough
testing for safety and effectiveness.
Most are also in extremely
limited supply, the FDA said. Two U.S. Ebola patients, Dr. Kent Brantly
and Nancy Writebol, are slowly recovering after receiving doses of one
experimental medicine called Zmapp. Only a handful of doses of the drug
have been manufactured so far, and prior to the patients receiving it
Zmapp had only been tested in animals.
The FDA also stressed that,
according to data from the U.S. Centers for Disease Control and
Prevention, Ebola does not pose a significant threat to the U.S. public.
The
virus is not a water-borne or food-borne illness and is not transmitted
through the air, the FDA said. Ebola is only spread through direct
contact with the body fluids of an infected person, or through needles
and other items that have been contaminated with the virus.
According
to the World Health Organization, the current outbreak of Ebola has
killed 1,066 people in Guinea, Liberia, Nigeria and Sierra Leona, and
sickened 2,000 more.
No comments:
Post a Comment